Home
Conditions
Communicable Diseases

Clinical trial condition

Communicable Diseases

Explore clinical trials studying Communicable Diseases. Study availability and eligibility vary by location and protocol.

9,174 public trials 550 recruiting studies

Refine in advanced search Browse all conditions

Communicable Diseases trial results

Completed

Dose Ranging of GSK2336805 in Combination Therapy

NCT01648140

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: GSK Investigational Site Dothan, Alabama, United States

GSK Investigational Site Anaheim, California, United States

GSK Investigational Site Los Angeles, California, United States

GSK Investigational Site DeLand, Florida, United States

View all 34 locations

View Trial Details

Completed

Fractures Stratified by HIV and Antiretroviral Therapy (ART) Status

NCT01077557

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +17 more
Locations: Not specified

View Trial Details

Completed

PENTA Fosamprenavir Study

NCT01077635

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

Immune Memory Foll Pry Vaccination With DTPw-HBV/Hib Vaccine Formulation; Immuno & Reacto of Booster Dose at 15-18 Mths

NCT00158808

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Blood-Borne Infections, +21 more
Locations: GSK Investigational Site City of Muntinlupa, Philippines

View Trial Details

Completed

Pilot Project of Virologic and Immunologic Correlates of GALT Immune Reconstitution Following Raltegravir Therapy

NCT00661960

Conditions: AIDS, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +15 more
Locations: CARES Clinic Sacramento, California, United States

UC Davis Medical Center Sacramento, California, United States

View Trial Details

Completed

Alcohol Pharmacotherapy for HIV+ Prisoners

NCT01077310

Conditions: AIDS, Acquired Immunodeficiency Syndrome, Alcohol Dependence, +23 more
Locations: Yale Clinical Research New Haven, Connecticut, United States

View Trial Details

Completed

Immunogenicity and Safety of an Adjuvanted HBV Vaccine Compared to Engerix™-B, in a Non-responder Population ≥ 15y

NCT00698061

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: Not specified

View Trial Details

Completed

Observational Study Of A Protease Inhibitor (PI) Containing Regimen In Subjects With PI Mutations Selected During Prior Treatment With GW433908 (Fosamprenavir)

NCT00242840

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +13 more
Locations: GSK Investigational Site Fort Lauderdale, Florida, United States

GSK Investigational Site Orlando, Florida, United States

GSK Investigational Site Tampa, Florida, United States

GSK Investigational Site Atlanta, Georgia, United States

View Trial Details

Completed

A Pilot Project of Virologic, Pharmacologic and Immunologic Correlates of Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution Following Maraviroc Therapy

NCT00870363

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: CARES Clinic Sacramento, California, United States

View Trial Details

Completed

Effects of L-Carnitine on Postprandial Clearance of Triglyceride-rich Lipoproteins in HIV Patients on HAART

NCT00386971

Conditions: Blood-Borne Infections, Communicable Diseases, Dyslipidemias, +17 more
Locations: GCRC UC Davis Sacramento, California, United States

View Trial Details

Communicable Diseases

Communicable Diseases trial results

Related conditions